Health leaders of tomorrow - the inaugural cohort of the INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance
The INEOS Oxbridge Doctoral Initiative on antimicrobial resistance is the flagship PhD programme of the Ineos Oxford Institute (IOI).
Designed to harness the combined expertise of two world-leading universities, Oxford and Cambridge, the initiative nurtures the next generation of scientific leaders to combat the threat of antimicrobial resistance (AMR).
The first cohort of students began their 4-year PhD projects from October 2023, and are co-supervised by professors at the universities of Cambridge and Oxford. Students are encouraged to spend time in both universities to learn new skills and expand their network of AMR collaborators.
The inaugural meeting brought the first cohort together for the first time, providing space for networking and stimulating discussion about each of their projects.
I enjoyed the chance to hear the diversity of the projects that my cohort are working on, all of which take a different angle to combat the threat of antimicrobial resistance. Everyone gave excellent presentations, and it was a great opportunity to be a part of the subsequent discussions where everyone, student or supervisor, was able to share their ideas."
The second cohort of students will begin their PhD projects in October 2023, which span multiple disciplines from health economics, public health, engineering and medical sciences.
AMR is not a global health threat that can be solved in silos. We need a co-ordinated approach involving different partners and disciplines. It was fantastic to see this reflected today in the diversity of projects, from machine learning to drug discovery to drug development.”
This is a very exciting opportunity to nurture impressive talent across the Universities of Oxford and Cambridge. This was only the first of many opportunities for the students to collaborate, and we are committed to building a diverse and inclusive network of early career researchers that will be the health leaders of tomorrow.”